文献速递创伤与烧伤重症综合管理与镇静镇痛

定义严重创伤后多器官衰竭:Denver、序贯器官衰竭评估与Marshall评分系统的比较

Defining multiple organ failure after major trauma: A comparison of the Denver, Sequential Organ Failure Assessment, and Marshall scoring systems.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论在严重创伤ICU患者中,不同MOF评分系统影响发生率与预后判断,作者推荐使用Denver评分,因其计算最简单且与早期创伤死亡关联最强。

该观察性队列研究在英国一家创伤中心纳入2003至2011年需ICU收治的严重创伤患者491例,比较Denver创伤后多器官衰竭评分、序贯器官衰竭评估(SOFA)和Marshall多器官功能障碍评分所描述的人群特征及对死亡的预测能力。主要终点为伤后100天内死亡。MOF发生率分别为Denver 22.8%、Marshall 40.5%、SOFA 58.5%;MOF定义不影响发生时间,但改变持续时间和器官衰竭模式。总死亡率为10.6%,Denver MOF与死亡风险增加关联最强(HR 3.87,95%CI 2.24-6.66)。各评分间ROC曲线下面积无显著差异;Denver特异性最高(81%),SOFA敏感性最高(73%)。作者推荐使用Denver评分。

要点

  • 在491例严重创伤ICU患者中,MOF发生率随评分系统不同而异:Denver 22.8%、Marshall 40.5%、SOFA 58.5%。
  • Denver MOF与死亡风险增加关联最强:HR 3.87(95%CI 2.24-6.66),总死亡率10.6%。
  • 各评分系统对死亡的ROC曲线下面积无显著差异,但Denver特异性最高(81%),SOFA敏感性最高(73%)。
  • MOF定义不影响发生时间,但改变MOF持续时间和器官衰竭模式。
  • 作者推荐使用Denver评分,因其计算最简单、可识别高风险患者群,且与早期创伤死亡关联最强。

适用人群与场景

  • 2003至2011年在英国一家创伤中心需ICU收治的严重创伤患者,共491例纳入创伤数据库。

诊断标准与关键阈值

  • Denver创伤后多器官衰竭评分、序贯器官衰竭评估(SOFA)和Marshall多器官功能障碍评分三种MOF评分系统,原文未给出各评分具体诊断阈值。

研究设计与关键结果

  • 研究类型为观察性队列研究,在英国一家创伤中心进行,纳入2003至2011年需ICU收治的严重创伤患者491例。
  • MOF发生率:Denver 22.8%,Marshall 40.5%,SOFA 58.5%。
  • MOF定义不影响发生时间,但改变MOF持续时间和器官衰竭模式。
  • 总死亡率为10.6%;Denver MOF与死亡风险增加关联最强(HR 3.87,95%CI 2.24-6.66)。
  • 各评分间ROC曲线下面积无显著差异;Denver特异性最高(81%),SOFA敏感性最高(73%)。

证据类型、等级与局限

  • 证据类型:观察性队列研究;证据等级:流行病学研究,level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者推荐使用Denver评分,因其计算最简单、可识别高风险患者群,且与早期创伤死亡关联最强。
  • 选择不同MOF评分系统会影响MOF发生率、持续时间、器官衰竭模式及死亡预测,床旁判读时需注意所用评分系统。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Postinjury multiple organ failure (MOF) remains a significant cause of morbidity and mortality. A large number of scoring systems have been proposed to define MOF, with no criterion standard. The purpose of this study was to compare three commonly used scores: the Denver Postinjury Multiple Organ Failure Score, the Sequential Organ Failure Assessment (SOFA), and the Marshall Multiple Organ Dysfunction Score, by descriptive analysis of the populations described by each score, and their predictive ability for mortality.

METHODS: An observational cohort study was performed at a UK trauma center on major trauma patients requiring intensive care unit admission from 2003 to 2011. A novel trauma database was created, merging national audit data with local electronic monitoring systems. Data were collected on demographics, laboratory results, pharmacy, interventions, and hourly physiological monitoring. The primary outcome measure was mortality within 100 days from injury. Sensitivity analyses and receiver operating characteristic curves were used to assess the predictive ability of MOF scores for mortality.

RESULTS: In total, 491 patients were included in the trauma database. MOF incidence ranged from 22.8% (Denver) to 40.5% (Marshall) to 58.5% (SOFA). MOF definition did not affect timing of onset, but did alter duration and organ failure patterns. Overall mortality was 10.6%, with Denver MOF associated with the greatest increased risk of death (hazard ratio 3.87, 95% confidence interval, 2.24-6.66). No significant difference was observed in area under the receiver operating characteristic curve values between scores. Marked differences were seen in relative predictors, with Denver showing highest specificity (81%) and SOFA highest sensitivity (73%) for mortality.

CONCLUSION: The choice of MOF scoring system affects incidence, duration, organ dysfunction patterns, and mortality prediction. We would recommend use of the Denver score since it is simplest to calculate, identifies a high-risk group of patients, and has the strongest association with early trauma mortality.

LEVEL OF EVIDENCE: Epidemiological study, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Hutchings L, Watkinson P, Young JD, et al. Defining multiple organ failure after major trauma: A comparison of the Denver, Sequential Organ Failure Assessment, and Marshall scoring systems. J Trauma Acute Care Surg. 2017. PMID: 28030507. doi:10.1097/TA.0000000000001328

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。